Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Receivables - Net: 2010-2025

Historic Receivables - Net for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $183.9 million.

  • BIO-TECHNE's Receivables - Net fell 17.79% to $183.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $183.9 million, marking a year-over-year decrease of 17.79%. This contributed to the annual value of $206.9 million for FY2025, which is 14.30% down from last year.
  • Latest data reveals that BIO-TECHNE reported Receivables - Net of $183.9 million as of Q3 2025, which was down 11.11% from $206.9 million recorded in Q2 2025.
  • BIO-TECHNE's 5-year Receivables - Net high stood at $241.4 million for Q2 2024, and its period low was $145.4 million during Q2 2021.
  • In the last 3 years, BIO-TECHNE's Receivables - Net had a median value of $217.9 million in 2024 and averaged $216.9 million.
  • In the last 5 years, BIO-TECHNE's Receivables - Net soared by 34.34% in 2021 and then dropped by 17.79% in 2025.
  • BIO-TECHNE's Receivables - Net (Quarterly) stood at $152.9 million in 2021, then increased by 20.84% to $184.8 million in 2022, then rose by 12.28% to $207.5 million in 2023, then increased by 5.06% to $217.9 million in 2024, then decreased by 17.79% to $183.9 million in 2025.
  • Its last three reported values are $183.9 million in Q3 2025, $206.9 million for Q2 2025, and $237.1 million during Q1 2025.